Clinical Trial: Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction

Brief Summary: The primary objective is to compare the safety of clopidogrel 50mg and 75mg in cerebral infarction with respect to incidence of bleeding adverse events.

Detailed Summary:
Sponsor: Sanofi

Current Primary Outcome: Incidence of bleeding adverse events [ Time Frame: study period ]

Original Primary Outcome: Incidence of bleeding adverse events

Current Secondary Outcome: Incidence of Serious Adverse Events, serious bleeding events, adverse events. Incidence of vascular events. [ Time Frame: study period ]

Original Secondary Outcome: Incidence of Serious Adverse Events, serious bleeding events, adverse events. Incidence of vascular events.

Information By: Sanofi

Dates:
Date Received: October 10, 2006
Date Started: September 2006
Date Completion:
Last Updated: February 23, 2010
Last Verified: February 2010